Proanthocyanidin in red rice inhibits MDA-MB-231 breast cancer cell invasion via the expression control of invasive proteins

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 4, 2015, Pages 571-581

  Pintha, Komsak ^a,b   Yodkeeree, Supachai ^a   Limtrakul, Pornngarm ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY OF PHAYAO   (Thailand)

Author keywords

Invasion; Nuclear factor kappa B; Proanthocyanidin; Red rice

Indexed keywords

CATECHIN; COLLAGENASE; DELPHINIDIN; EPICATECHIN; EPIGALLOCATECHIN; GALLOCATECHIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR 1; PROANTHOCYANIDIN; PROCYANIDIN; PRODELPHINIDIN; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; ANTINEOPLASTIC AGENT; IL6 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC50; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RED RICE; RICE; 3T3 CELL LINE; ANIMAL; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; ORYZA; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; NF-KAPPA B; NIH 3T3 CELLS; ORYZA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROANTHOCYANIDINS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84929466645     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00719     Document Type: Article

References (45)

1. Kotepui M, Chupeerach C. Age distribution of breast cancer from a Thailand population-based cancer registry. Asian Pac. J. Cancer Prev., 14, 3815-3817 (2013).
2. Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim. Biophys. Acta, 1786, 87-104 (2008).
3. Tang L, Han X. The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed. Pharmacother., 67, 179-182 (2013).
4. Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast, 22 (Suppl. 2), S66-S72 (2013).
5. Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta, 1799, 775-787 (2010).
6. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem. Pharmacol., 72, 1605-1621 (2006).
7. Gunaratne A, Wu K, Li D, Bentota A, Corke H, Cai YZ. Anti-oxidant activity and nutritional quality of traditional red-grained rice varieties containing proanthocyanidins. Food Chem., 138, 1153-1161 (2013).
8. Feng LL, Liu BX, Zhong JY, Sun LB, Yu HS. Effect of grape pro-cyanidins on tumor angiogenesis in liver cancer xenograft models. Asian Pac. J. Cancer Prev., 15, 737-741 (2014).
9. Dinicola S, Pasqualato A, Cucina A, Coluccia P, Ferranti F, Cani-pari R, Catizone A, Proietti S, D'Anselmi F, Ricci G, Palombo A, Bizzarri M. Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion. Eur. J. Nutr., 53, 421-431 (2014).
10. Pintha K, Yodkeeree S, Pitchakarn P, Limtrakul P. Anti-invasive activity against cancer cells of phytochemicals in red jasmine rice (Oryza sativa L.). Asian Pac. J. Cancer Prev., 15, 4601-4607 (2014).
11. Oki T, Masuda M, Kobayashi M, Nishiba Y, Furuta S, Suda I, Sato T. Polymeric procyanidins as radical-scavenging components in red-hulled rice. J. Agric. Food Chem., 50, 7524-7529 (2002).
12. Hsieh MC, Shen YJ, Kuo YH, Hwang LS. Antioxidative activity and active components of longan (Dimocarpus longan Lour.) flower extracts. J. Agric. Food Chem., 56, 7010-7016 (2008).
13. Yodkeeree S, Wongsirisin P, Pompimon W, Limtrakul P. Anti-invasion effect of crebanine and O-methylbulbocapnine from Stephania venosa via down-regulated matrix metalloproteinases and urokinase plasminogen activator. Chem. Pharm. Bull., 61, 1156-1165 (2013).
14. Pérez-Jiménez J, Arranz S, Saura-Calixto F. Proanthocyanidin content in foods is largely underestimated in the literature data: An approach to quantification of the missing proanthocyanidins. Food Res. Int., 42, 1381-1388 (2009).
15. Bordiga M, Gomez-Alonso S, Locatelli M, Travaglia F, Coïsson JD, Hermosin-Gutierrez I, Arlorio M. Phenolics characterization and antioxidant activity of six different pigmented Oryza sativa L. culti-vars grown in Piedmont (Italy). Food Res. Int., 65, 282-290 (2014).
16. Min B, Gu L, McClung AM, Bergman CJ, Chen M-H. Free and bound total phenolic concentrations, antioxidant capacities, and profiles of proanthocyanidins and anthocyanins in whole grain rice (Oryza sativa L.) of different bran colours. Food Chem., 133, 715-722 (2012).
17. Labarbe B, Cheynier V, Brossaud F, Souquet JM, Moutounet M. Quantitative fractionation of grape proanthocyanidins according to their degree of polymerization. J. Agric. Food Chem., 47, 2719-2723 (1999).
18. Jerez M, Sineiro J, Guitián E, Núñez MJ. Identification of polymeric procyanidins from pine bark by mass spectrometry. Rapid Commun. Mass Spectrom., 23, 4013-4018 (2009).
19. Hellström JK, Mattila PH. HPLC determination of extractable and unextractable proanthocyanidins in plant materials. J. Agric. Food Chem., 56, 7617-7624 (2008).
20. Tsang C, Auger C, Mullen W, Bornet A, Rouanet J-M, Crozier A, Teissedre P-L. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr., 94, 170-181 (2005).
21. Niu YG, Gao BY, Slavin M, Zhang XW, Yang F, Bao JS, Shi HM, Xie ZH, Yu LL. Phytochemical compositions, and antioxidant and anti-inflammatory properties of twenty-two red rice samples grown in Zhejiang. Lwt-Food Sci. Technol., 54, 521-527 (2013).
22. Pintha K, Yodkeeree S, Pitchakarn P, Limtrakul P. Anti-invasive activity against cancer cells of phytochemicals in red jasmine rice (Oryza sativa L.). Asian Pac. J. Cancer Prev., 15, 4601-4607 (2014).
23. Lewandowska U, Szewczyk K, Owczarek K, Hrabec Z, Podsedek A, Sosnowska D, Hrabec E. Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis. Nutr. Cancer, 65, 1219-1231 (2013).
24. Galliera E, Tacchini L, Corsi Romanelli MM. Matrix metallopro-teinases as biomarkers of disease: updates and new insights. Clin. Chem. Lab. Med., 53, 349-355 (2014).
25. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J. Nutr. Biochem., 20, 87-95 (2009).
26. Lee H, Chang KW, Yang HY, Lin PW, Chen SU, Huang YL. MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 437, 232-238 (2013).
27. Artacho-Cordón F, Ríos-Arrabal S, Lara PC, Artacho-Cordón F, Calvente I, Núñez MI. Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast rad iot her apy. Surg. Oncol., 21, e143-e151 (2012).
28. Strek M, Gorlach S, Podsedek A, Sosnowska D, Koziolkiewicz M, Hrabec Z, Hrabec E. Procyanidin oligomers from Japanese quince (Chaenomeles japonica) fruit inhibit activity of MMP-2 and MMP-9 metalloproteinases. J. Agric. Food Chem., 55, 6447-6452 (2007).
29. Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RA. Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells. Biochem. Cell Biol., 83, 637-643 (2005).
30. Abd-Allah SH, Shalaby SM, Pasha HF, El-Shal AS, Abou El-Saoud AM. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoar-thritis. Genet. Test. Mol. Bioma., 16, 15-20 (2012).
31. Andres SA, Edwards AB, Wittliff JL. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance. J. Clin. Lab. Anal., 26, 93-103 (2012).
32. Palmirotta R, Ferroni P, Savonarola A, Martini F, Ciatti F, Laudisi A, Sini V, Del Monte G, Guadagni F, Roselli M. Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer. Thromb. Res., 124, 403-408 (2009).
33. Aune G, Stunes AK, Lian AM, Reseland JE, Tingulstad S, Torp SH, Syversen U. Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma. Results Immunol., 2, 190-195 (2012).
34. Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev., 34, 122-136 (2008).
35. Mekkawy AH, Pourgholami MH, Morris DL. Involvement of uro-kinase-type plasminogen activator system in cancer: an overview. Med. Res. Rev., 34, 918-956 (2014).
36. Praus M, Collen D, Gerard RD. Both u-Pa inhibition and vitronec-tin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int. J. Cancer, 102, 584-591 (2002).
37. Meryet-Figuières M, Resina S, Lavigne C, Barlovatz-Meimon G, Lebleu B, Thierry AR. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range. Biochimie, 89, 1228-1233 (2007).
38. Sandra D, Radha M, Harishkumar M, Yuichi N, Sayuri O, Masugi M. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Phytomedicine, 17, 42-46 (2010).
39. Wang Y, Li LZ, Guo XQ, Jin X, Sun WJ, Zhang XL, Xu RC. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine, 59, 228-236 (2012).
40. Choi YK, Cho SG, Woo SM, Yun YJ, Park S, Shin YC, Ko SG. Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling. Mediat. Inflamm., 2014, 492173 (2014).
41. Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr. Med. Chem., 14, 377-386 (2007).
42. Schröder C, Witzel I, Müller V, Krenkel S, Wirtz RM, Jänicke F, Schumacher U, Milde-Langosch K. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer. J. Cancer Res. Clin. Oncol., 137, 1193-1201 (2011).
43. Kalin R, Righi A, Del Rosso A, Bagchi D, Generini S, Guiducci S, Cerinic MM, Das DK. Activin, a grape seed-derived proanthocyani-din extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic. Res., 36, 819-825 (2002).
44. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 71, 1397-1421 (2006).
45. Uchino R, Madhyastha R, Madhyastha H, Dhungana S, Nakajima Y, Omura S, Maruyama M: NF-kappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 21, 528-533 (2010).